Ropivacaine
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- China
- Payment Terms
- Negotiable
- Production method
- Negotiable
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- ropivacaine, 84057-95-4, c17h26n2o
- Category
- Organic Intermediate
Wuhan KangMei Biotechnology Co., Ltd
China
- Verified Certificate
-
6
| Product name | Ropivacaine | Certification | - |
|---|---|---|---|
| Category | Organic Intermediate | Ingredients | - |
| Keyword | ropivacaine , 84057-95-4 , c17h26n2o | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | China | Stock | - |
| Supply type | - | HS code | - |
Product Information
Product:Ropivacaine
CAS NO.: 84057-95-4
Purity: 99%min
Appearance:white powder
Molecular fomula : C17H26N2O
Application :an anaesthetic agent and blocks impulse conduction in nerve fibres through inhibiting sodium ion influx reversibly
Packaging: as you need
Storage : keep in cool and dry place
Shipping term :By air express or by sea sea
B2B Trade
| Price (FOB) | Negotiable | transportation | - |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Negotiable | Shipping time | Negotiable |
- President
- Ren beibei
- Address
- Wuchang district, Wuhan city, Hubei
- Product Category
- Pharmaceutical Intermediates
- Year Established
- 2015
- No. of Total Employees
- 51-100
- Company introduction
-
Wuhan KangMei Biotechnology Co., Ltd. specializing in pharmaceutical intermediates, general reagents, chromatography reagents and other chemical products, we have five subsidiaries, in the industry with high visibility, while enjoying tax-free benefits.
Company platform has accumulated a large number of conventional chemical supplier and scarce intermediates custom supplier resources. To provide quality chemicals more than 100000 kinds of products including laboratory reagents, intermediates, bulk commodities, natural ingredients and active pharmaceutical ingredients. Also provide custom synthesis chemicals (non-commercial).And timely grasp the development of pharmaceutical products markets. Has extensive overseas sales market.
- Main Product
